Comparative analysis of breast cancer mortality following mammography screening in Denmark and Norway

Annals of Oncology

Volumn 25, Issue 6, 2014, Pages 1137-1143

  Kalager, Mette ^a,b,c   Loberg M ^a,c,d   Bretthauer, M ^c,d   Adami, H O ^a,c,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b TELEMARK HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Effectiveness; Mammography; Mortality; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; COMPARATIVE STUDY; CONTROLLED STUDY; DENMARK; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HISTORICAL PERIOD; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NORWAY; PRIORITY JOURNAL; BREAST TUMOR; EARLY DIAGNOSIS; EPIDEMIOLOGY; MASS SCREENING; MIDDLE AGED; MORTALITY;

AGED; BREAST NEOPLASMS; DENMARK; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NORWAY;

EID: 84902577942     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu122     Document Type: Article

References (40)

1. Harvard School of Public Health. The Forum. http://www.hsph.harvard.edu/forum/events/mammograms (25 May 2012, date last accessed).
2. Vainio H, Bianchini F (eds). IARC Handbook of Cancer Prevention Volume 7. Breast Cancer Screening. Vol 7. Lyon, France: IARC Press; 2002: http://www.iarc.fr/en/publications/pdfs-online/prev/handbook7/Handbook7_Breast.pdf (1 June 2012, date last accessed).
3. Nelson HD, Tyne K, Naik A et al. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med 2009; 151(10): 727-737.
4. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009; Issue 4(4). http://www.ncbi.nlm.nih.gov/pubmed/19821284 (19 May 2011, date last accessed).
5. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365(9472): 1687-1717.
6. Autier P, Boniol M, Gavin A et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011; 343: d4411.
7. Berry DA, Cronin KA, Plevritis SK et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353(17): 1784-1792.
8. Blanks RG, Moss SM, McGahan CE et al. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000; 321(7262): 665-669.
9. Kalager M, Zelen M, Langmark F et al. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 2010; 363(13): 1203-1210.
10. Autier P, Boniol M, LaVecchia C et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 2010; 341: c3620.
11. Jørgensen KJ, Zahl PH, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 2010; 340: c1241.
12. Olsen AH, Njor SH, Vejborg I et al. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005; 330(7485): 220-224.
13. Vejborg I, Olsen AH, Jensen MB et al. Early outcome of mammography screening in Copenhagen 1991-99. J Med Screen 2002; 9(3): 115-119.
14. Njor SH, Olsen AH, Bellstrom T et al. Mammography screening in the county of F. November 1993-December 1999. APMIS Suppl 2003; 111(110): 1-33.
15. Danish Breast Cancer Cooperative Group. Kvalitetsindikatorrapport for brystkræft. 2010; http://www.dbcg.dk/PDF%20Filer/Kvalitetsindikatorrapport%202010_ Webversion.pdf (25 May 2012, date last accessed).
16. Utzon-Frank N, Vejborg I, von Euler-Chelpin M et al. Balancing sensitivity and specificity: sixteen year's of experience from the mammography screening programme in Copenhagen, Denmark. Cancer Epidemiol 2011; 35(5): 393-398.
17. Perry N, Broeders M, de Wolf C et al. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006: http://screening.iarc.fr/doc/ND7306954ENC_002.pdf (19 May 2011, date last accessed).
18. Ertzaas AK (ed.). Quality Assurance Manual of the Norwegian Breast Cancer Screening Program. 3rd ed. Oslo, Norway: The Cancer Registry of Norway; 2003: http://kreftregisteret.no/Global/Kvalitetsmanualer/kvalitetsmanual_mammografiprogrammet.pdf (19 May 2011, date last accessed).
19. Kalager M, Kåresen R, Wist E. [Survival after breast cancer-differences between Norwegian counties]. Tidsskr Nor Laegeforen 2009; 129(24): 2595-2600.
20. Lynge E, Olsen AH. Reduction in mortality from breast cancer: authors' reply. BMJ 2005; 330(7498): 1025.
21. The Association of the Nordic Cancer Registries. NORDCAN Database. 2012; http://www-dep.iarc.fr/NORDCAN/English/frame.asp (20 May 2011, date last accessed).
22. Engholm G, Ferlay J, Christensen N et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010; 49(5): 725-736. http://www.ncbi.nlm.nih.gov/pubmed/20491528 (20 May 2011, date last accessed).
23. Nyström L, Andersson I, Bjurstam N et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359 (9310): 909-919.
24. Ursin G. Mammographic screening debate on study design: a need to move the field forward. BMC Med 2012; 10(1): 164.
25. Olsen AH, Lynge E, Njor SH et al. Breast cancer mortality in Norway after the introduction of mammography screening. Int J Cancer 2013; 132(1): 208-214.
26. Jensen A, Olsen AH, von Euler-Chelpin M et al. Do nonattenders in mammography screening programmes seek mammography elsewhere? Int J Cancer 2005; 113 (3): 464-470.
27. Mouridsen HT, Bjerre KD, Christiansen P et al. Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry. Acta Oncol 2008; 47(4): 525-536.
28. Rostgaard K, Væth M, Rootzen H et al. Why did the breast cancer lymph node status distribution improve in Denmark in the pre-mammography screening period of 1978-1994? Acta Oncol 2010; 49(3): 313-321.
29. Kalager M, Haldorsen T, Bretthauer M et al. Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study. Breast Cancer Res 2009; 11(4): R44.
30. Kalager M, Adami HO, Bretthauer M et al. Overdiagnosis of Invasive Breast Cancer Due to Mammography Screening: results from the Norwegian Screening Program. Ann Intern Med 2012; 156(7): 491-499.
31. Autier P. Mammography screening before introduction of the national breast screening programme in Norway. Int J Cancer 2013; 132(7): 1721-1722.
32. Kalager M, Løberg M, Bretthauer M. Limited use of nonprogram screening in Norway. Int J Cancer 2013; 132(7): 1723-1724.
33. Jørgensen KJ, Zahl PH, Gøtzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health 2009; 9(1): 36.
34. Sørum R, Hofvind S, Skaane P et al. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast 2010; 19(6): 499-505.
35. Hery C, Ferlay J, Boniol M et al. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 2008; 19(6): 1187-1194.
36. Fischerman K, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). Structure and results of the organization. Acta Oncol 1988; 27(6A): 593-596.
37. Jensena AR, Ewertz M, Cold S et al. Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark. Eur J Cancer 2003; 39(12): 1783-1793.
38. Andreasen AH, Mouridsen HT, Andersen KW et al. [Improved prognosis of breast cancer]. Ugeskr Laeger 1994; 156(44): 6512-6517.
39. Eaker S, Dickman PW, Bergkvist L et al. Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med 2006; 3(3): e25.
40. Early breast cancer trialists group. Systemic treatment of early breast-cancer by hormonal, cytotoxic, or immune therapy-133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 1992; 339(8785): 71-85.